The pandemic dominated healthcare in 2020, but it won’t be recognized as a reason to delay complying with CMS’ price transparency mandate, which went into effect on Jan. 1, 2021. In a recent study conducted by HealthAffairs indicated 65 of the 100 largest hospitals in… Read More »Healthcare Transparency: Pandemic cool down turns up regulatory heat
Will handshakes become a thing of the past? Will face masks become a regular feature of flu season? Will home-working remain popular, even after workplaces re-open? COVID-19 forced some abrupt behavior changes that challenged existing cultural norms, but as the pandemic subsides, how many of… Read More »Beyond the pandemic: digital patient intake is here to stay
The life sciences history industry has some unique challenges when it comes to compliance. But if you think third party compliance risks are bad, don’t take your eye off fourth and fifth parties, says Allan Matheson. Early life science pioneers in foreign markets earned a… Read More »Hidden compliance risks for life sciences companies
Experts to come together for compliance event exploring ‘validation ready’ global labeling systems Wokingham, United Kingdom — 27 April 2021 — A group of industry experts is set to explore how medical device, clinical trial and pharmaceutical companies can proactively manage labeling risk. The complimentary online event, hosted by… Read More »Experts to come together for compliance event ‘validation ready’ global labeling systems
Despite a 20-year head start, providers still fall short of HIPAA requirements around fulfilling patient requests for their medical records. In light of the federal information blocking rules, providers should first examine their compliance with HIPAA and then address the new demands imposed by the… Read More »Compliance with HIPAA may offer some clues on how providers will fare with new info blocking rules
The federal price transparency rule for hospitals went into effect Jan. 1, but a new analysis shows that a majority of providers studied were “unambiguously noncompliant.”
Many players in life sciences and other sectors balk at updating their compliance systems because of the cost and resources involved. but addressing possible lapses now can save your company millions of dollars in fines and reputational damage.
The Office of the Inspector General will audit Medicare Part B telehealth services to detect potential vulnerabilities and ensure compliance with regulatory requirements. To prepare, providers must first take stock of their programs and conduct audits of their own, experts say.
By Jennifer Mercer, CEO of Metazoa Jennifer Mercer is Co-founder and CEO of Metazoa, developers of Snapshot, an admin and developer tool for companies with complex Salesforce orgs that is used by over 60% of Fortune 100 companies. Salesforce org management is usually not the… Read More »A Message to Pharma CIOs: Optimizing Salesforce Improves Security and Compliance
CMS has finalized changes to the Physician Self-Referral Law, also known as Stark Law. Healthcare law experts say that these changes will generally make it easier for hospitals and physicians to remain in compliance with the statute.
Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. It can help address well established issues with studies, such as patient recruitment and retention, as… Read More »Increasing patient engagement with UK clinical trials
As every healthcare executive knows, a healthy revenue cycle relies on precise paperwork. That’s why all Medicare providers should be paying close attention to the revised medical necessity form, which will be mandatory starting January 1, 2021. Failure to use the new Advance Beneficiary Notice… Read More »Q&A with Experian Health senior director of data compliance on CMS updates for Medicare ABN forms